scholarly article | Q13442814 |
P2093 | author name string | David Feifel | |
Kai Macdonald | |||
P2860 | cites work | Oxytocin Attenuates Affective Evaluations of Conditioned Faces and Amygdala Activity | Q22255499 |
Intranasal oxytocin reduces psychotic symptoms and improves Theory of Mind and social perception in schizophrenia | Q84759806 | ||
Oxytocin Modulates Neural Circuitry for Social Cognition and Fear in Humans | Q22255501 | ||
Vasopressin and Oxytocin Excite Distinct Neuronal Populations in the Central Amygdala | Q22299356 | ||
Structure and expression of a human oxytocin receptor | Q24336185 | ||
The human amygdala is necessary for developing and expressing normal interpersonal trust | Q24601049 | ||
Adult attachment predicts maternal brain and oxytocin response to infant cues | Q24619346 | ||
From ultrasocial to antisocial: a role for oxytocin in the acute reinforcing effects and long-term adverse consequences of drug use? | Q24648383 | ||
Molecular mechanisms of antidiuretic effect of oxytocin | Q24649233 | ||
Oxytocin receptor genetic variation relates to empathy and stress reactivity in humans | Q24656041 | ||
Emergent synchronous bursting of oxytocin neuronal network | Q27336767 | ||
Oxytocin responsivity in mothers of infants: a preliminary study of relationships with blood pressure during laboratory stress and normal ambulatory activity | Q28141014 | ||
Biobehavioral responses to stress in females: tend-and-befriend, not fight-or-flight | Q28143505 | ||
The oxytocin receptor system: structure, function, and regulation | Q28207331 | ||
Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review | Q28215767 | ||
Neural circuit regulation of prepulse inhibition of startle in the rat: current knowledge and future challenges | Q28215773 | ||
Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies | Q28215775 | ||
A neurobiological basis of social attachment | Q28239295 | ||
Oxytocin increases trust in humans | Q28254266 | ||
Social defeat: risk factor for schizophrenia? | Q28264772 | ||
Oxytocin is associated with human trustworthiness | Q28267939 | ||
Central vasopressin and oxytocin release: regulation of complex social behaviours | Q28288549 | ||
Oxytocin attenuates the cocaine-induced exploratory hyperactivity in mice | Q28334562 | ||
Prenatal stress generates deficits in rat social behavior: Reversal by oxytocin | Q28577893 | ||
CNS region-specific oxytocin receptor expression: importance in regulation of anxiety and sex behavior | Q28578718 | ||
The expression of neuropeptide-induced excessive grooming behavior in dopamine D1 and D2 receptor-deficient mice | Q28584808 | ||
Schizophrenia, "Just the Facts" 6. Moving ahead with the schizophrenia concept: from the elephant to the mouse | Q28727394 | ||
Structural pathology underlying neuroendocrine dysfunction in schizophrenia | Q30409351 | ||
The effects of oxytocin and its analog, carbetocin, on genetic deficits in sensorimotor gating | Q30427738 | ||
The environment and susceptibility to schizophrenia | Q30459929 | ||
Oxytocin, dopamine, and the amygdala: a neurofunctional model of social cognitive deficits in schizophrenia | Q30464312 | ||
Clozapine and PD149163 elevate prepulse inhibition in Brown Norway rats | Q30468932 | ||
A review of emotion deficits in schizophrenia | Q30473420 | ||
Diminished plasma oxytocin in schizophrenic patients with neuroendocrine dysfunction and emotional deficits | Q30492008 | ||
A hormone-activated central pattern generator for courtship | Q30494213 | ||
Different amygdala subregions mediate valence-related and attentional effects of oxytocin in humans | Q30494974 | ||
Evidence for a role of oxytocin receptors in the long-term establishment of dominance hierarchies | Q30504499 | ||
Reduced anterior hippocampal formation volume in hyponatremic schizophrenic patients | Q31108960 | ||
Clozapine, but not haloperidol, reverses social behavior deficit in mice during withdrawal from chronic phencyclidine treatment. | Q31997655 | ||
Different antipsychotics elicit different effects on magnocellular oxytocinergic and vasopressinergic neurons as revealed by Fos immunohistochemistry | Q33506130 | ||
Protocol for an experimental investigation of the roles of oxytocin and social support in neuroendocrine, cardiovascular, and subjective responses to stress across age and gender | Q33520115 | ||
Prefrontal cortical deficits and impaired cognition-emotion interactions in schizophrenia | Q33603714 | ||
Phencyclidine in the social interaction test: an animal model of schizophrenia with face and predictive validity | Q33651662 | ||
The challenge of translation in social neuroscience: a review of oxytocin, vasopressin, and affiliative behavior | Q33761364 | ||
Mesotocin and nonapeptide receptors promote estrildid flocking behavior | Q33821150 | ||
Oxytocin-dopamine interactions mediate variations in maternal behavior in the rat. | Q33848243 | ||
Naturally occurring variations in maternal behavior in the rat are associated with differences in estrogen-inducible central oxytocin receptors | Q33948059 | ||
Promise and pitfalls of animal models of schizophrenia | Q33956579 | ||
Reduced prefrontal activity predicts exaggerated striatal dopaminergic function in schizophrenia | Q33957624 | ||
Oxytocin-induced analgesia and scratching are mediated by the vasopressin-1A receptor in the mouse | Q33989258 | ||
Adjunctive intranasal oxytocin reduces symptoms in schizophrenia patients | Q34023024 | ||
Natural variations in maternal and paternal care are associated with systematic changes in oxytocin following parent-infant contact | Q34098554 | ||
Sniffing neuropeptides: a transnasal approach to the human brain | Q34126887 | ||
Oral versus depot antipsychotic drugs for schizophrenia--a critical systematic review and meta-analysis of randomised long-term trials | Q34160338 | ||
Oxytocin selectively gates fear responses through distinct outputs from the central amygdala | Q34196729 | ||
The Steroid/Peptide Theory of Social Bonds: integrating testosterone and peptide responses for classifying social behavioral contexts | Q34197062 | ||
Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: A systematic review and meta-analysis | Q34213209 | ||
Peripheral oxytocin is associated with reduced symptom severity in schizophrenia | Q34311629 | ||
Vasopressin and oxytocin release within the brain: a dynamic concept of multiple and variable modes of neuropeptide communication | Q34374925 | ||
Oxytocin receptor gene polymorphism (rs2254298) interacts with familial risk for psychopathology to predict symptoms of depression and anxiety in adolescent girls. | Q34384624 | ||
Dendritic peptide release and peptide-dependent behaviours | Q34486938 | ||
A meta-analysis of the efficacy of second-generation antipsychotics | Q34534321 | ||
Oxytocin attenuates amygdala responses to emotional faces regardless of valence | Q34580947 | ||
Stimulation of dopamine receptors in the paraventricular nucleus of the hypothalamus of male rats induces penile erection and increases extra-cellular dopamine in the nucleus accumbens: Involvement of central oxytocin. | Q34590214 | ||
Association of the oxytocin receptor (OXTR) gene polymorphisms with autism spectrum disorder (ASD) in the Japanese population. | Q34616103 | ||
Social effects of oxytocin in humans: context and person matter | Q34630520 | ||
The acute effects of intranasal oxytocin administration on endocrine and sexual function in males. | Q34765587 | ||
Oxytocin shapes the neural circuitry of trust and trust adaptation in humans | Q34781060 | ||
Antidiuretic effects of oxytocin, morphine and pethidine in pregnancy and labour | Q79442202 | ||
Implicit trustworthiness decisions: automatic coding of face properties in the human amygdala | Q80831010 | ||
Oxytocin revisited: It is also a cardiovascular hormone | Q84088933 | ||
Variants in the oxytocin gene and risk for schizophrenia | Q84402564 | ||
Oxytocin-messages via the cerebrospinal fluid: behavioral effects; a review | Q37759344 | ||
Gender-related endocrinological dysfunction and mental disorders. | Q37760007 | ||
Dopamine and oxytocin interactions underlying behaviors: potential contributions to behavioral disorders. | Q37765942 | ||
The relationship between neurocognition and social cognition with functional outcomes in schizophrenia: a meta-analysis | Q37771567 | ||
Central control of penile erection: a re-visitation of the role of oxytocin and its interaction with dopamine and glutamic acid in male rats | Q37807128 | ||
Antipsychotic occupancy of dopamine receptors in schizophrenia | Q37818511 | ||
A review of safety, side-effects and subjective reactions to intranasal oxytocin in human research. | Q37856511 | ||
Sexual dimorphism in schizophrenia: is there a need for gender-based protocols? | Q37896624 | ||
Oxytocin and vasopressin in the human brain: social neuropeptides for translational medicine | Q37919724 | ||
Does dopamine play a role in schizophrenia? | Q39177114 | ||
From maps to mechanisms through neuroimaging of schizophrenia | Q39818506 | ||
The environment and schizophrenia | Q39958490 | ||
An historical review of the use of oxytocin prior to delivery | Q40032772 | ||
Cortical maldevelopment, anti-psychotic drugs, and schizophrenia: a search for common ground | Q40424300 | ||
Neurohypophysial peptides in cerebrospinal fluid: an update | Q40846755 | ||
Breastfeeding: physiological, endocrine and behavioural adaptations caused by oxytocin and local neurogenic activity in the nipple and mammary gland | Q41127783 | ||
Neurochemical sensitization in the pathophysiology of schizophrenia: deficits and dysfunction in neuronal regulation and plasticity | Q41608731 | ||
The acoustic startle response in rats--circuits mediating evocation, inhibition and potentiation | Q41706989 | ||
Prepulse startle deficit in the Brown Norway rat: a potential genetic model | Q41738580 | ||
Oxytocin suppresses basal glutamatergic transmission but facilitates activity-dependent synaptic potentiation in the medial prefrontal cortex | Q42493116 | ||
Hippocampal microinfusion of oxytocin attenuates the behavioural response to stress by means of dynamic interplay with the glucocorticoid-catecholamine responses | Q43093674 | ||
Oxytocin is neuroprotective against oxygen-glucose deprivation and reoxygenation in immature hippocampal cultures | Q43095354 | ||
Schizophrenia severity and clozapine treatment outcome association with oxytocinergic genes | Q43144926 | ||
Dopamine-oxytocin interactions in penile erection | Q43175428 | ||
Phencyclidine-induced psychosis | Q43637366 | ||
A double-blind comparative study of clozapine and risperidone in the management of severe chronic schizophrenia | Q43692964 | ||
Plasma levels of oxytocin during the menstrual cycle, pregnancy and following treatment with HMG. | Q43899652 | ||
Female Oxytocin-Deficient Mice Display Enhanced Anxiety-Related Behavior | Q44440486 | ||
Prolactin and oxytocin interaction in the paraventricular and supraoptic nuclei: effects on oxytocin mRNA and nitric oxide synthase | Q44465665 | ||
Oxytocin, but not oxytocin receptor, is rRegulated by oestrogen receptor beta in the female mouse hypothalamus. | Q44496769 | ||
Nucleus accumbens oxytocin and dopamine interact to regulate pair bond formation in female prairie voles | Q44624436 | ||
Effect of a single dose of des-glycinamide-[Arg8]vasopressin or oxytocin on cognitive processes in young healthy subjects | Q44758720 | ||
Dopamine release in response to a psychological stress in humans and its relationship to early life maternal care: a positron emission tomography study using [11C]raclopride. | Q44804073 | ||
Oxytocin attenuates stress-induced c-fos mRNA expression in specific forebrain regions associated with modulation of hypothalamo-pituitary-adrenal activity. | Q44814703 | ||
Variations in nucleus accumbens dopamine associated with individual differences in maternal behavior in the rat. | Q44872451 | ||
Effects of oxytocin in normal man during low and high sodium diets | Q44924061 | ||
Oxytocin and vasopressin genes are significantly associated with schizophrenia in a large Arab-Israeli pedigree | Q45032796 | ||
Neuropeptide regulation of social behavior in a monogamous cichlid fish | Q45094544 | ||
Prenatal exposure to a repeated variable stress paradigm elicits behavioral and neuroendocrinological changes in the adult offspring: potential relevance to schizophrenia. | Q45175683 | ||
Menstrual cycle-related changes in plasma oxytocin are relevant to normal sexual function in healthy women | Q45233376 | ||
Localization of oxytocin binding sites in the human brainstem and upper spinal cord: an autoradiographic study | Q45304416 | ||
Social interaction prevents the development of depressive-like behavior post nerve injury in mice: a potential role for oxytocin | Q45765486 | ||
Effects of oxytocin on methamphetamine-induced conditioned place preference and the possible role of glutamatergic neurotransmission in the medial prefrontal cortex of mice in reinstatement | Q46048577 | ||
Reproductive hormones in plasma over the menstrual cycle in primary dysmenorrhea compared with healthy subjects | Q46287289 | ||
Social interaction deficits caused by chronic phencyclidine administration are reversed by oxytocin | Q46411318 | ||
Oxytocin and neurophysin in plasma and CSF during suckling in the guinea-pig | Q46442163 | ||
Oxytocin modulates psychotomimetic-induced deficits in sensorimotor gating | Q46595907 | ||
Effects of partner support on resting oxytocin, cortisol, norepinephrine, and blood pressure before and after warm partner contact | Q46620706 | ||
Oxytocin as a natural antipsychotic: a study using oxytocin knockout mice | Q46785915 | ||
Schizophrenia, "just the facts" what we know in 2008. 2. Epidemiology and etiology | Q34783101 | ||
Mechanism of action of clozapine in the context of dopamine D1-D2 receptor hetero-dimerization--a working hypothesis. | Q34898825 | ||
Effects of intranasal oxytocin on emotional face processing in women | Q34994119 | ||
Molecular approaches to aggregation behavior and social attachment | Q35027422 | ||
Sex-specific associations between peripheral oxytocin and emotion perception in schizophrenia | Q35115758 | ||
Developmental consequences of oxytocin | Q35211185 | ||
Oxytocin — A neuropeptide for affiliation: Evidence from behavioral, receptor autoradiographic, and comparative studies | Q35229289 | ||
Oxytocin receptors in the central nervous system. Distribution, development, and species differences | Q35230045 | ||
A dopaminergic deficit hypothesis of schizophrenia: the path to discovery | Q35236663 | ||
Animal behavior models of the mechanisms underlying antipsychotic atypicality | Q35595230 | ||
Emotion recognition and oxytocin in patients with schizophrenia | Q35647312 | ||
Effects of intranasal oxytocin and vasopressin on cooperative behavior and associated brain activity in men. | Q35653107 | ||
Is nose-to-brain transport of drugs in man a reality? | Q35673938 | ||
Cortical cholinergic transmission and cortical information processing in schizophrenia | Q36124290 | ||
Structure and comparison of the oxytocin and vasopressin genes from rat | Q36266006 | ||
How do we know the minds of others? Domain-specificity, simulation, and enactive social cognition | Q36409312 | ||
Oxytocin stimulates adult neurogenesis even under conditions of stress and elevated glucocorticoids | Q36588279 | ||
Effect of antipsychotic medication alone vs combined with psychosocial intervention on outcomes of early-stage schizophrenia: A randomized, 1-year study | Q36784855 | ||
Stimuli and consequences of dendritic release of oxytocin within the brain | Q36979768 | ||
Randomized controlled trial of effect of prescription of clozapine versus other second-generation antipsychotic drugs in resistant schizophrenia | Q37075939 | ||
Stress and the hypothalamic pituitary adrenal axis in the developmental course of schizophrenia | Q37120692 | ||
Novel aspects of glutamatergic signalling in the neuroendocrine system | Q37207345 | ||
Steroidal/neuropeptide interactions in hypothalamus and amygdala related to social anxiety. | Q37227027 | ||
Oxytocin, vasopressin and sociality | Q37227032 | ||
Oxytocin, vasopressin, and the neurogenetics of sociality | Q37319197 | ||
Dopaminergic-neuropeptide interactions in the social brain | Q37351370 | ||
The effects of antipsychotic medications on emotion perception in patients with chronic schizophrenia in the CATIE trial | Q37394738 | ||
Social cognition and interaction training (SCIT) for outpatients with schizophrenia: a preliminary study | Q37409812 | ||
Oxytocin and the development of parenting in humans | Q37618794 | ||
The peptide that binds: a systematic review of oxytocin and its prosocial effects in humans | Q37667058 | ||
Inhibition by oxytocin of methamphetamine-induced hyperactivity related to dopamine turnover in the mesolimbic region in mice | Q46842190 | ||
Dynamic changes in oxytocin receptor expression and activation at parturition in the rat brain | Q48106830 | ||
Divergent effects of two different doses of intranasal oxytocin on facial affect discrimination in schizophrenic patients with and without polydipsia | Q48154990 | ||
Dopamine neurotransmission in the nucleus accumbens may be involved in oxytocin-enhanced grooming behavior of the rat. | Q48350508 | ||
Diminished glucocorticoid negative feedback in polydipsic hyponatremic schizophrenic patients | Q48362857 | ||
Morphometric evaluation of neurophysin-immunoreactivity in the human brain: pronounced inter-individual variability and evidence for altered staining patterns in schizophrenia. | Q48381391 | ||
Striatal vs extrastriatal dopamine D2 receptors in antipsychotic response--a double-blind PET study in schizophrenia | Q48381678 | ||
Oxytocin improves long-lasting spatial memory during motherhood through MAP kinase cascade | Q48382169 | ||
The interface of oxytocin-labeled cells and serotonin transporter-containing fibers in the primate hypothalamus: a substrate for SSRIs therapeutic effects? | Q48398177 | ||
Apomorphine stimulation of vasopressin- and oxytocin-neurophysins. Evidence for increased oxytocinergic and decreased vasopressinergic function in schizophrenics | Q48417307 | ||
Water intoxication and hyponatremic encephalopathy from the use of an oxytocin nasal spray. A case report | Q48514911 | ||
Nitric oxide synthase-containing neurons in the human hypothalamus: reduced number of immunoreactive cells in the paraventricular nucleus of depressive patients and schizophrenics | Q48522635 | ||
Localization of high-affinity binding sites for oxytocin and vasopressin in the human brain. An autoradiographic study | Q48675360 | ||
Oxytocin in the medial amygdala is essential for social recognition in the mouse. | Q48764530 | ||
Effects of oxytocin, des-glycinamide-oxytocin and anti-oxytocin serum on the α-MPT-induced disappearance of catecholamines in the rat brain | Q48795542 | ||
Vasopressin and oxytocin release in the brain--a synaptic event | Q48860592 | ||
The influence of depressive symptomatology and perceived stress on plasma and salivary oxytocin before, during and after a support enhancement intervention | Q48884097 | ||
Relationships among estrogen receptor, oxytocin and vasopressin gene expression and social interaction in male mice | Q49057898 | ||
Maternal and paternal plasma, salivary, and urinary oxytocin and parent-infant synchrony: considering stress and affiliation components of human bonding | Q49162376 | ||
Association between the oxytocin receptor gene and amygdalar volume in healthy adults. | Q50302270 | ||
Pharmacologic rescue of impaired cognitive flexibility, social deficits, increased aggression, and seizure susceptibility in oxytocin receptor null mice: a neurobehavioral model of autism. | Q50312848 | ||
Interaction of 5-HTTLPR and a variation on the oxytocin receptor gene influences negative emotionality. | Q50652337 | ||
Effects of long-term treatment with oxytocin in chronic constipation; a double blind, placebo-controlled pilot trial. | Q50956590 | ||
Sharing secrets: oxytocin and trust in schizophrenia. | Q51887808 | ||
Cerebrospinal fluid oxytocin concentration in schizophrenic patients does not differ from control subjects and is not changed by neuroleptic medication. | Q52028971 | ||
Vasopressin--oxytocin in cerebrospinal fluid of schizophrenic patients and normal controls. | Q52207888 | ||
Human memory and neurohypophyseal hormones: opposite effects of vasopressin and oxytocin. | Q52212982 | ||
The effect of oral contraceptive pills on levels of oxytocin in plasma and on cognitive functions. | Q52254576 | ||
Experimental peripheral administration of oxytocin elevates a suite of cooperative behaviours in a wild social mammal | Q55174635 | ||
Schizophrenia | Q55868331 | ||
Oxytocin as a moderator of hypnotizability | Q57244593 | ||
Oxytocin Modulates Amygdala, Insula, and Inferior Frontal Gyrus Responses to Infant Crying: A Randomized Controlled Trial | Q57823304 | ||
Previous maternal experience potentiates the effect of parturition on oxytocin receptor mRNA expression in the paraventricular nucleus | Q59925983 | ||
Estrogen, menstrual cycle phases, and psychopathology in women suffering from schizophrenia | Q60608697 | ||
Amperozide and clozapine but not haloperidol or raclopride increase the secretion of oxytocin in rats | Q67527076 | ||
Pattern of oxytocin concentrations in the plasma and cerebrospinal fluid of lactating rhesus monkeys (Macaca mulatta): evidence for functionally independent oxytocinergic pathways in primates | Q68586064 | ||
Psychotropic properties of oxytocin | Q69599024 | ||
Responses of plasma oxytocin and arginine vasopressin to nausea induced by apomorphine and ipecacuanha | Q69924386 | ||
Circulating immunoreactive oxytocin during the human menstrual cycle comes from the pituitary and is estradiol dependent | Q69948866 | ||
Hormones in the treatment of psychoses | Q70508353 | ||
Cerebrospinal fluid neurophysins in affective illness and in schizophrenia | Q70644691 | ||
A time-dependent peak of oxytocin exists in cerebrospinal fluid but not in plasma of humans | Q71042707 | ||
[Psychotropic properties of oxytocin] | Q71338247 | ||
Immunohistochemistry of vasopressin, oxytocin and neurophysin in the hypothalamus and extrahypothalamic regions of the human and primate brain | Q71548759 | ||
Penetration of neurohypophyseal hormones from plasma into cerebrospinal fluid (CSF): half-times of disappearance of these neuropeptides from CSF | Q71680670 | ||
Hyponatraemia and non-electrolyte solutions in labouring primigravida | Q72015301 | ||
Serum profiles of oxytocin during oral contraceptive treatment | Q72758570 | ||
P433 | issue | 3 | |
P921 | main subject | schizophrenia | Q41112 |
oxytocin | Q169960 | ||
P304 | page(s) | 130-146 | |
P577 | publication date | 2011-12-19 | |
P1433 | published in | Acta Neuropsychiatrica | Q4676734 |
P1476 | title | Oxytocin in schizophrenia: a review of evidence for its therapeutic effects | |
P478 | volume | 24 |
Q38593718 | A Review of Oxytocin's Effects on the Positive, Negative, and Cognitive Domains of Schizophrenia |
Q30408983 | A Role for Oxytocin in the Etiology and Treatment of Schizophrenia |
Q38192728 | A meta-analysis and theoretical critique of oxytocin and psychosis: prospects for attachment and compassion in promoting recovery |
Q90505279 | Acoustic prepulse inhibition in male and female prairie voles: Implications for models of neuropsychiatric illness |
Q38977500 | Apathy in Dementia: Systematic Review of Recent Evidence on Pharmacological Treatments |
Q34532471 | Association between oxytocin receptor gene polymorphisms and self-rated 'empathic concern' in schizophrenia |
Q34624043 | Associations between oxytocin receptor genotypes and social cognitive performance in individuals with schizophrenia |
Q91318349 | Can the new epidemiology of schizophrenia help elucidate its causation? |
Q37022856 | Characterization of the effects of oxytocin on fear recognition in patients with schizophrenia and in healthy controls |
Q30382281 | Current and emergent treatments for symptoms and neurocognitive impairment in schizophrenia. |
Q38223714 | Development of novel therapy of schizophrenia in children and adolescents. |
Q60937279 | Endogenous oxytocin response to film scenes of attachment and loss is pronounced in schizophrenia |
Q26770469 | From Autism to Eating Disorders and More: The Role of Oxytocin in Neuropsychiatric Disorders |
Q36685572 | Helping oxytocin deliver: considerations in the development of oxytocin-based therapeutics for brain disorders |
Q36106577 | Increased Serum Levels of Oxytocin in 'Treatment Resistant Depression in Adolescents (TRDIA)' Group |
Q43438262 | Interactions of vasopressin and oxytocin receptors with vasopressin analogues substituted in position 2 with 3,3'-diphenylalanine--a molecular docking study. |
Q38674187 | Intranasal Oxytocin May Improve High-Level Social Cognition in Schizophrenia, But Not Social Cognition or Neurocognition in General: A Multilevel Bayesian Meta-analysis |
Q30372084 | Low-dose oxytocin delivered intranasally with Breath Powered device affects social-cognitive behavior: a randomized four-way crossover trial with nasal cavity dimension assessment. |
Q38652239 | On the role of oxytocin in borderline personality disorder |
Q47731855 | Oxytocin and MDMA ('Ecstasy') enhance social reward in rats |
Q38675134 | Oxytocin and Social Cognitions in Schizophrenia: A Systematic Review |
Q26768063 | Oxytocin and Vasopressin Receptor Gene Polymorphisms: Role in Social and Psychiatric Traits |
Q35646296 | Oxytocin and social cognition in affective and psychotic disorders |
Q37126568 | Oxytocin and socioemotional aging: Current knowledge and future trends |
Q50303936 | Oxytocin and vasopressin levels are decreased in the plasma of male schizophrenia patients. |
Q60619756 | Oxytocin bei Schizophrenie |
Q38683538 | Oxytocin effects in schizophrenia: Reconciling mixed findings and moving forward |
Q30659389 | Oxytocin reduces amygdala activity, increases social interactions, and reduces anxiety-like behavior irrespective of NMDAR antagonism |
Q36238675 | Oxytocin system dysfunction as a common mechanism underlying metabolic syndrome and psychiatric symptoms in schizophrenia and bipolar disorders |
Q37088090 | Oxytocin's effect on resting-state functional connectivity varies by age and sex |
Q38336027 | Oxytocin, testosterone, and human social cognition |
Q26749390 | Peripheral oxytocin and vasopressin: Biomarkers of psychiatric disorders? A comprehensive systematic review and preliminary meta-analysis |
Q33761384 | Potential of Oxytocin in the Treatment of Schizophrenia |
Q26824603 | Research review: Social motivation and oxytocin in autism--implications for joint attention development and intervention |
Q38261819 | Social neuroscience in psychiatry: unravelling the neural mechanisms of social dysfunction. |
Q51141409 | Testing synaptic plasticity in dynamic mate choice decisions: N-methyl D-aspartate receptor blockade disrupts female preference. |
Q30355076 | The Neurobiological Basis for Social Affiliation in Autism Spectrum Disorder and Schizophrenia. |
Q38603574 | The neurobiology of mammalian parenting and the biosocial context of human caregiving |
Q28066450 | The relationship between central and peripheral oxytocin concentrations: a systematic review and meta-analysis protocol |
Q33994774 | The role of oxytocin in psychiatric disorders: a review of biological and therapeutic research findings |